Primary |
Glaucoma |
22.7% |
Sjogren's Syndrome |
22.7% |
Dry Mouth |
18.2% |
Cataract |
4.5% |
Drug Use For Unknown Indication |
4.5% |
Dry Eye |
4.5% |
Gastritis Prophylaxis |
4.5% |
Insomnia |
4.5% |
Postoperative Care |
4.5% |
Product Used For Unknown Indication |
4.5% |
Stomatitis |
4.5% |
|
Drug Ineffective |
11.8% |
Vertigo |
11.8% |
Chest Pain |
5.9% |
Death |
5.9% |
Hypersomnia |
5.9% |
Liver Function Test Abnormal |
5.9% |
Malaise |
5.9% |
Pallor |
5.9% |
Pupillary Disorder |
5.9% |
Sick Sinus Syndrome |
5.9% |
Tremor |
5.9% |
Urinary Retention |
5.9% |
Urticaria |
5.9% |
Vertigo Cns Origin |
5.9% |
Visual Acuity Reduced |
5.9% |
|
Secondary |
Product Used For Unknown Indication |
20.3% |
Glaucoma |
17.7% |
Drug Use For Unknown Indication |
10.1% |
Intraocular Pressure Increased |
10.1% |
Angle Closure Glaucoma |
8.9% |
Ocular Hypertension |
6.3% |
Ill-defined Disorder |
5.1% |
Chronic Obstructive Pulmonary Disease |
2.5% |
Eye Pain |
2.5% |
Neuralgia |
2.5% |
Sleep Disorder |
2.5% |
Visual Acuity Reduced |
2.5% |
Anorexia |
1.3% |
Blood Pressure |
1.3% |
Depression |
1.3% |
Dry Mouth |
1.3% |
Insomnia |
1.3% |
Macular Oedema |
1.3% |
Migraine |
1.3% |
|
Visual Acuity Reduced |
15.0% |
Haemorrhage |
10.0% |
Rectal Haemorrhage |
10.0% |
Therapeutic Agent Toxicity |
10.0% |
Transaminases Increased |
10.0% |
Headache |
5.0% |
Intraocular Pressure Increased |
5.0% |
Ocular Hypertension |
5.0% |
Orthostatic Hypotension |
5.0% |
Speech Disorder |
5.0% |
Uveitis |
5.0% |
Vision Blurred |
5.0% |
Visual Impairment |
5.0% |
Vitreous Floaters |
5.0% |
|
Concomitant |
Drug Use For Unknown Indication |
39.1% |
Product Used For Unknown Indication |
23.1% |
Rheumatoid Arthritis |
12.5% |
Glaucoma |
5.7% |
Breast Cancer |
2.5% |
Depression |
2.4% |
Pain |
2.1% |
Hypertension |
1.7% |
Acute Myeloid Leukaemia |
1.4% |
Sjogren's Syndrome |
1.3% |
Vitamin Supplementation |
1.1% |
Osteoarthritis |
1.0% |
Pancreatic Neuroendocrine Tumour |
1.0% |
Breast Cancer Metastatic |
0.8% |
Dry Mouth |
0.8% |
Renal Cell Carcinoma |
0.8% |
Cardiac Failure Congestive |
0.7% |
Fibromyalgia |
0.7% |
Metastatic Gastric Cancer |
0.7% |
Dental Care |
0.6% |
|
Vomiting |
13.9% |
Weight Decreased |
8.9% |
Generalised Oedema |
7.6% |
Spinal Osteoarthritis |
7.6% |
Vision Blurred |
6.3% |
Malaise |
5.1% |
Metabolic Encephalopathy |
5.1% |
Peritonitis |
5.1% |
Convulsion |
3.8% |
Intraocular Pressure Increased |
3.8% |
Scleroderma |
3.8% |
Sepsis |
3.8% |
Sudden Death |
3.8% |
Tachycardia |
3.8% |
Unevaluable Event |
3.8% |
Weight Increased |
3.8% |
Cerebrovascular Accident |
2.5% |
Disease Progression |
2.5% |
Drug Ineffective |
2.5% |
Gastrointestinal Haemorrhage |
2.5% |
|